Cellectis S.A.
CLLS
$3.59
$0.092.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -544.41% | 102.55% | 6.07% | -421.25% | 114.17% |
| Total Depreciation and Amortization | -23.57% | 6.17% | 6.11% | 7.92% | -0.82% |
| Total Amortization of Deferred Charges | 61.87% | -- | -- | -- | 998.55% |
| Total Other Non-Cash Items | 171.67% | -41.02% | 76.47% | 129.45% | -198.68% |
| Change in Net Operating Assets | -126.07% | -350.74% | -120.11% | -26.18% | -91.09% |
| Cash from Operations | -21,942.55% | 73.05% | -119.76% | 26.40% | -100.12% |
| Capital Expenditure | 12.91% | -51.99% | 70.62% | -81.19% | -99.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 242.33% | -109.78% | 50.27% | 351.94% | -20.45% |
| Cash from Investing | 234.75% | -115.41% | 50.47% | 305.90% | -22.04% |
| Total Debt Issued | -- | -- | -- | -- | 395.61% |
| Total Debt Repaid | -8.87% | -0.42% | 0.71% | 4.60% | 7.10% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 49.07% | 34.98% | -19.14% | 33.19% | 89.96% |
| Cash from Financing | -241.54% | -1.00% | -105.44% | -134.38% | -92.97% |
| Foreign Exchange rate Adjustments | 165.21% | 176.15% | -129.24% | 628.84% | -220.46% |
| Miscellaneous Cash Flow Adjustments | -150.00% | 150.00% | -- | -- | 300.00% |
| Net Change in Cash | 158.66% | -175.32% | -360.16% | -13.67% | -122.83% |